GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $61,000 | +125.9% | 892 | +6.8% | 0.00% | – |
| Q2 2022 | $27,000 | -6.9% | 835 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | +20.8% | 835 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +14.3% | 835 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -36.4% | 835 | -12.5% | 0.00% | – |
| Q2 2021 | $33,000 | -19.5% | 954 | -5.3% | 0.00% | – |
| Q1 2021 | $41,000 | 0.0% | 1,007 | +6.0% | 0.00% | – |
| Q4 2020 | $41,000 | – | 950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |